The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
27 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $15,311,629 in first-year total cost, median $547,519.
Most frequent study sections
- Special Emphasis Panel[ZCA1 RPRB-6 (M2)]11
- Special Emphasis Panel[ZCA1 TCRB-9 (J1)]6
- Special Emphasis Panel[ZCA1 TCRB-9 (J2)]5
- Special Emphasis Panel[ZCA1 TCRB-V (O1)]5
Most frequent institutions
- FRED HUTCHINSON CANCER CENTER2
- OREGON HEALTH & SCIENCE UNIVERSITY2
- UNIVERSITY OF PENNSYLVANIA2
- BECKMAN RESEARCH INSTITUTE/CITY OF HOPE1
- BOSTON UNIVERSITY MEDICAL CAMPUS1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2025 | Symptomatic Toxicities & Quality of Life among Diverse Individuals Receiving Immune Checkpoint Inhibitors for Metastatic Cancer.1R37CA288566-01A1 | MORENO, PATRICIA INGRID | UNIVERSITY OF MIAMI SCHOOL OF MEDICINE, FL | $1,131,820 | ZCA1 |
| 2025 | PROACT: Promoting Follow-up of Abnormal Colorectal Cancer Screening Tests through Multilevel Interventions1R37CA295618-01 | ISSAKA, RACHEL B. | FRED HUTCHINSON CANCER CENTER, WA | $621,406 | ZCA1 |
| 2025 | Targeting T Cells for enhancing anti-tumor immunity in pediatric brain tumors.1R37CA288506-01A1 | GANESAN, ANUSHA PREETHI | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $546,308 | ZCA1 |
| 2025 | Endoplasmic Reticulum Stress in the function of cancer associated fibroblasts in pancreatic cancer1R01CA295509-01 | BARBOSA VENDRAMINI COSTA, DÉBORA | HENRY FORD HEALTH + MICHIGAN STATE UNIVERSITY HEALTH SCIENCES, MI | $435,144 | ZCA1 |
| 2025 | Determining Barriers Leading to Inferior Survival for Black and Hispanic Patients with Hodgkin Lymphoma: A Patient-Centered Study1R37CA288560-01A1 | MAILHOT, RAYMOND BMOBLEY, ERIN M | UNIVERSITY OF FLORIDA, FL | $384,340 | ZCA1 |
| 2024 | Examining the Impact of Structural Racism on African American Non-Small Cell Lung Cancer Mutational Signatures and Outcomes1R37CA284040-01A1 | ERHUNMWUNSEE, LORETTA | BECKMAN RESEARCH INSTITUTE/CITY OF HOPE, CA | $1,027,816 | ZCA1 |
| 2024 | Positive Psychology Intervention for Hematopoietic Stem Cell Transplantation Survivors1R37CA288557-01 | AMONOO, HERMIONI L. | BRIGHAM AND WOMEN'S HOSPITAL, MA | $746,926 | ZCA1 |
| 2024 | Optical Genome Mapping As a Novel Diagnostic Approach in Pediatric Brain Tumors1R01CA288496-01 | BARSEGHYAN, HAYKBORNHORST, MIRIAM A. | LURIE CHILDREN'S HOSPITAL OF CHICAGO, IL | $699,080 | ZCA1 |
| 2024 | Partnerships to Reduce Obesity in Community Health Center Patients1R01CA283950-01A1 | DEL FIOL, GUILHERMESCHLECHTER, CHELSEYWETTER, DAVID W | UNIVERSITY OF UTAH, UT | $631,100 | ZCA1 |
| 2024 | Structural Racism and Cardiovascular Outcomes Among Cancer Survivors1R37CA288492-01 | PINHEIRO, LAURA C | WEILL MEDICAL COLL OF CORNELL UNIV, NY | $594,823 | ZCA1 |
| 2024 | Social Genomic Mechanisms Linking Structural Racism, Perceived Discrimination, and Breast Cancer Survival1R37CA288502-01 | GOEL, NEHA | SLOAN-KETTERING INST CAN RESEARCH, NY | $582,548 | ZCA1 |
| 2024 | Leveraging Biologically Specific PET/MRI Monitoring and Therapeutic Modulation of the Hypoxic Glioblastoma Tumor Immune Microenvironment into Improved Outcomes1R37CA288577-01 | BARAJAS, RAMON FRANCISCO | OREGON HEALTH & SCIENCE UNIVERSITY, OR | $547,519 | ZCA1 |
| 2024 | The Role of TGFβ2 and Macrophages in Cancer Cachexia1R01CA288578-01 | VELAZQUEZ, KANDY T | UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA, SC | $524,709 | ZCA1 |
| 2024 | Deciphering mechanisms of transcriptional repression which drive midline glioma1R01CA288596-01 | PHILLIPS, RICHARD E | UNIVERSITY OF PENNSYLVANIA, PA | $475,431 | ZCA1 |
| 2024 | Improving anti-tumor immunity in advanced breast cancer by targeting solid stress1R01CA284133-01A1 | JONES, DENNIS | BOSTON UNIVERSITY MEDICAL CAMPUS, MA | $451,940 | ZCA1 |
| 2024 | Characterization of NUP205 as a haploinsufficient essential gene for the treatment of hematopoietic malignancies1R37CA284012-01A1 | ZHANG, HAIJIAO | OREGON HEALTH & SCIENCE UNIVERSITY, OR | $378,405 | ZCA1 |
| 2023 | Interrogating Mechanisms of Anti-tumor Immunity in Human Subjects and Murine Models of IDH-Mutant Glioma Treated with All-Trans Retinoic Acid and PD-1 Inhibition1R37CA284132-01 | AMANKULOR, NDUKA MGBECHINYERE | UNIVERSITY OF PENNSYLVANIA, PA | $683,099 | ZCA1 |
| 2023 | Tailored prostate cancer screening: addressing USPSTF priority research gaps in a racially-diverse study population1R01CA283896-01 | LANGSTON, MARVIN EPOLIANSUTCLIFFE, SIOBHAN | STANFORD UNIVERSITY, CA | $680,237 | ZCA1 |
| 2023 | Early response to radiotherapy and immunotherapy in rectal cancer: an integrated molecular, cellular, and spatial approach1R01CA283953-01 | AGUILERA, TODD A | UT SOUTHWESTERN MEDICAL CENTER, TX | $656,670 | ZCA1 |
| 2023 | Evaluating Centralizing Interventions to Address Low Adherence to Lung Cancer Screening Follow-up in Decentralized Settings1R01CA284032-01 | TRIPLETTE, MATTHEW ADAM | FRED HUTCHINSON CANCER CENTER, WA | $560,138 | ZCA1 |
| 2023 | Pathways, a Hope-Based Intervention to Support Personal Goal Pursuit, Mental Health, and Quality of Life during Advanced Lung Cancer Treatment1R01CA283929-01 | MCLOUTH, LAURIE | UNIVERSITY OF KENTUCKY, KY | $547,576 | ZCA1 |
| 2023 | RepurPosed AntiretrOviraL ThErapieS to EliminAte Cervical Cancer (POLESA Trial)1R37CA284033-01 | PINDER, LEEYA F | UNIVERSITY OF CINCINNATI, OH | $511,276 | ZCA1 |
| 2023 | Therapeutic targeting of CD206+ TAMs to enhance adaptive and innate anti-tumor immune responses in metastatic castration-resistant prostate cancer1R01CA283649-01 | ZARIF, JELANI CHINELO | JOHNS HOPKINS UNIVERSITY, MD | $457,524 | ZCA1 |
| 2023 | Elucidating the mechanism of Ga13 mediated tumor suppression in pancreatic cancer1R01CA283925-01 | SHIELDS, MARIO | NORTHWESTERN UNIVERSITY AT CHICAGO, IL | $423,251 | ZCA1 |
| 2023 | Deciphering the role of NELFE in modulating MYC signaling in HCC1R01CA284017-01 | DANG, HIEN T. | THOMAS JEFFERSON UNIVERSITY, PA | $368,321 | ZCA1 |
| 2023 | Defining the Biological Arc of Grade Group 1 Prostate Cancer1R37CA283857-01 | SALAMI, SIMPA SAMUEL | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $356,850 | ZCA1 |
| 2023 | Multifunctional Nanoparticle Platform to Prevent Alcohol-Associated HCC Development1R37CA283937-01 | MENON, JYOTHI UNNIKRISHNA | UNIVERSITY OF RHODE ISLAND, RI | $287,372 | ZCA1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.